Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.verified

VNDA

Price:

$5.2

Market Cap:

$307.28M

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule ...[Read more]

Industry

Biotechnology

IPO Date

2006-04-12

Stock Exchange

NASDAQ

Ticker

VNDA

The PE Ratio as of December 2025 (TTM) for Vanda Pharmaceuticals Inc. (VNDA) is -3.61

According to Vanda Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.61. This represents a change of -35.25% compared to the average of -5.58 of the last 4 quarters.

Vanda Pharmaceuticals Inc. (VNDA) Historical PE Ratio (quarterly & annually)

How has VNDA PE Ratio performed in the past?

The mean historical PE Ratio of Vanda Pharmaceuticals Inc. over the last ten years is 17.37. The current -3.61 PE Ratio has changed -2178.35% with respect to the historical average. Over the past ten years (40 quarters), VNDA's PE Ratio was at its highest in in the September 2023 quarter at 453.43. The PE Ratio was at its lowest in in the September 2016 quarter at -420.99.

Quarterly (TTM)
Annual

Average

17.37

Median

16.92

Minimum

-43.43

Maximum

96.51

Vanda Pharmaceuticals Inc. (VNDA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vanda Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 306.11%

Maximum Annual PE Ratio = 96.51

Minimum Annual Increase = -221.39%

Minimum Annual PE Ratio = -43.43

Quarterly (TTM)
Annual
YearPE RatioChange
2024-14.74-115.27%
202396.5145.14%
202266.49152.93%
202126.29-14.21%
202030.65306.11%
20197.55-85.69%
201852.72-221.39%
2017-43.4312.86%
2016-38.48289.98%
2015-9.87-140.00%

Vanda Pharmaceuticals Inc. (VNDA) Average PE Ratio

How has VNDA PE Ratio performed in the past?

The current PE Ratio of Vanda Pharmaceuticals Inc. (VNDA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

49.42

5-year avg

41.04

10-year avg

17.37

Vanda Pharmaceuticals Inc. (VNDA) PE Ratio vs. Peers

How is VNDA’s PE Ratio compared to its peers?

Vanda Pharmaceuticals Inc.’s PE Ratio is greater than Achieve Life Sciences, Inc. (-4.66), greater than Entrada Therapeutics, Inc. (-4.07), greater than Humacyte, Inc. (-10.58), less than Voyager Therapeutics, Inc. (-2.02), less than Atea Pharmaceuticals, Inc. (-1.90), greater than Arcturus Therapeutics Holdings Inc. (-3.71), less than Allogene Therapeutics, Inc. (-1.51), less than Sagimet Biosciences Inc. (-3.57), greater than Immuneering Corporation (-3.87), greater than Capricor Therapeutics, Inc. (-16.59),

Build a custom stock screener for Vanda Pharmaceuticals Inc. (VNDA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vanda Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vanda Pharmaceuticals Inc. (VNDA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vanda Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Vanda Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for Vanda Pharmaceuticals Inc. (VNDA)?

What is the highest PE Ratio for Vanda Pharmaceuticals Inc. (VNDA)?

What is the 3-year average PE Ratio for Vanda Pharmaceuticals Inc. (VNDA)?

What is the 5-year average PE Ratio for Vanda Pharmaceuticals Inc. (VNDA)?

How does the current PE Ratio for Vanda Pharmaceuticals Inc. (VNDA) compare to its historical average?